Since its first description in Japan 30 years ago, Kawasaki disease has bee
n reported worldwide. Although an infectious etiology is suspected based on
the epidemiology and clinical features, a causative agent has not been ide
ntified. The majority of the morbidity and mortality associated with this c
ondition is attributable to the development of coronary artery aneurysms. T
reatment during the acute phase with intravenous immunoglobulin and acetyls
alicylic acid results in significant reductions in coronary complications.
The long-term management of patients with persistent coronary abnormalities
is less well-defined. This article reviews the epidemiology, possible etio
logies, and management of Kawasaki disease.